Sarcoid-Like Mediastinal Lymphadenopathy in Gynecologic Malignancy

Table 1

Age	Primary malignancy	FIGO stage at diagnosis	Sampled LN station	PET scan	PET uptake	Initial chemotherapy	Lymphadenopathy on initial staging CT scan	Duration in which patient was followed after EBUS and remained disease-free
66	Endometrial Adenocarcinoma	IA	4R, 7, 12L	Positive	L hilum maximal SUV of 6.6. Infracarinal maximal SUV of 6.9.; R hilum maximal SUV of 6.2	No chemotherapy advised	Mediastinal lymphadenopathy present on initial staging CT	2 years
68	Serous ovarian carcinoma	IIIB	7 and 11R	Positive	R hilar maximal SUV of 3.7	Taxol IV, Cisplatin intraperitoneal, and Taxol intraperitoneal	None	1 year
33	Serous ovarian carcinoma	IIIA	4R, 7, 11R	N/A	N/A	Taxol/Cisplatin chemotherapy	None	3 years
67	Serous fallopian carcinoma	IIIC	4R, 7, 10R	N/A	N/A	N/A	None	N/A
58	Endometrial Adenocarcinoma	IC	4R, 7, 11R	N/A	N/A	N/A	None	4 years